Wall Street Analysts See a 69.15% Upside in Fulcrum Therapeutics (FULC): Can the Stock Really Move This High?

Fulcrum Therapeutics, Inc. (FULC) closed the last trading session at $7.91, gaining 6.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 13.38 indicates a 69.2% upside potential. The average comprises eight short-term price targets ranging from a low of $5 to a high of$ 19, with a standard deviation of $5.13. While the lowest estimate indicates a decline of 36.8% from the current ...